Dr. Hegenberger is Emerald Clinical’s VP, Scientific and Medical Affairs. He is an MD, specialized in Internal Medicine, with an MBA, an MSc in Pharmaceutical Science, and postgraduate certifications from Georgetown University (International Business), Mount Sinai Hospital (Internal Medicine), and Harvard (Nanobiotechnology).  He became an Associate Prof. of Internal Medicine in 2 main universities in Buenos Aires. He was transferred to Vienna for 3 years, and then to Madrid on 2024, where he is based now. Claudio leads the Scientific and Clinical Affairs Team, and supports Business Development (BD) as the medical lead for strategy discussions, proposal development, and BDMs across key therapeutic areas.

Claudio comes to Emerald Clinical after serving as VP of Medical Affairs at Pfizer Inc. He has 27 years of Pharma industry experience, including Country, Regional and Global Medical Affairs and Clinical Research roles, having extensive experience in Clinical Operations, CROs’ supervision, Pharmacovigilance, Medical Information, Safety Reporting, as well as supervising Country Medical Directors, TA Medical Leads and platform lines across all therapeutic areas (IM, I&I, Vaccines, Oncology, Rare Diseases and Hospital line). He fluently speaks English, Spanish, and German, as well as basic Portuguese.